Cytespace Africa Labs Enhances Molecular Testing Capacity
Cytespace Africa Laboratories, part of MLM Medical Labs, has made significant strides in expanding its molecular testing capabilities, responding to the increasing demand for clinical trials across Sub-Saharan Africa. This expansion, marked by the installation of multiple Roche cobas 5800 systems, has resulted in a tripling of the laboratory's molecular diagnostic throughput.
Impact on Clinical Trials
With advanced technology in place, Cytespace is now positioned to conduct high-volume, fully automated PCR testing. This capability plays a crucial role in supporting a broad spectrum of clinical trials, particularly in the realm of infectious diseases, where timely and accurate diagnostics are paramount.
Meeting the Needs of High-Burden Diseases
The laboratory’s strategic enhancement allows it to offer invaluable support to sponsors conducting vaccine and therapeutic trials for pressing health concerns such as HIV, Hepatitis B and C, and a variety of sexually transmitted infections (STIs). As the healthcare landscape continues to evolve, Cytespace remains a pivotal partner in combating health challenges faced in the region.
Advanced Technology Adoption
“With our new cobas platforms, we've significantly advanced our ability to deliver high-throughput, IVD-licensed molecular testing with rapid turnaround times,” stated Sorika van Niekerk, Managing Director at Cytespace Africa Laboratories. These systems now enable confirmatory and viral load testing for HIV-1/2, and quantitative assessments for Hepatitis B and C.
Moreover, the new platforms support expanded testing capabilities for a range of conditions, including HPV genotyping and respiratory infections, ensuring that Cytespace is equipped to address evolving health concerns effectively.
Integrated Diagnostics and Logistics
Cytespace operates with a one-roof model, integrating molecular diagnostics alongside flow cytometry, clinical chemistry, and hematology services. This unique structure not only enhances operational efficiency but also ensures comprehensive sample management, covering both outbound and inbound logistics, which facilitates quicker study startups.
Building Partnerships for Clinical Research
This ambitious investment further solidifies Cytespace's role as a leading clinical trial laboratory partner throughout Africa. With full accreditation from CAP and compliance with ISO 15189 standards, the lab ensures the delivery of consistent results that upholds the highest quality and reliability for clinical trials.
Scott Houlton, CEO of MLM Medical Labs, emphasized the importance of localized capabilities in clinical research: “As global sponsors increasingly turn to South Africa for clinical research, we are proud to invest in capabilities that reduce complexity, cost, and time to data.” Cytespace's expansion allows for faster startup times, fewer shipment delays, and stronger regional oversight of clinical trials.
Invitation to Collaborate
Cytespace warmly invites pharmaceutical sponsors, contract research organizations (CROs), and non-governmental organizations (NGOs) to engage with their expert team. This is an opportunity to leverage the enhanced capabilities of Cytespace to streamline clinical trial execution in the region.
About MLM Medical Labs
MLM Medical Labs is a prominent international central and specialty laboratory with harmonized operations across Europe, North America, and Africa. With over three decades of experience, MLM supports a plethora of clinical trials, offering services from central lab testing to biomarker discovery and more. The organization is well-regarded for its scientific expertise and commitment to regulatory compliance.
About Cytespace Africa Laboratories
Cytespace Africa Laboratories holds the distinction of being the only fully CAP-accredited central laboratory in South Africa, integrated under one roof. Established in 1999, it has provided support for over 1,200 trials, serving as a trusted partner for global sponsors navigating the complexities of clinical research within Africa.
Frequently Asked Questions
What recent advancements has Cytespace Africa Labs made?
Cytespace has expanded its molecular testing capabilities with new Roche cobas 5800 systems, tripling its diagnostic throughput.
Why is molecular testing crucial for clinical trials?
Molecular testing is essential for accurately diagnosing and monitoring various diseases, thereby supporting effective clinical trial outcomes.
What diseases is Cytespace focusing on for clinical trials?
Cytespace is particularly focused on supporting trials for diseases like HIV, Hepatitis B and C, and other high-burden infectious diseases.
How does Cytespace ensure quality in its testing?
Cytespace is fully accredited by CAP and complies with ISO 15189 standards, ensuring high-quality diagnostics and data integrity.
Who can partner with Cytespace Africa Laboratories?
Pharmaceutical sponsors, CROs, and NGOs looking for reliable clinical trial execution can partner with Cytespace to leverage its expertise and resources.
